{"id":"NCT00004228","sponsor":"Children's Oncology Group","briefTitle":"Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma","officialTitle":"Randomized Phase III Study for the Treatment of Newly Diagnosed Disseminated Lymphoblastic Lymphoma or Localized Lymphoblastic Lymphoma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2000-06","primaryCompletion":"2008-08","completion":"2015-03-31","firstPosted":"2003-01-27","resultsPosted":"2013-12-05","lastUpdate":"2019-08-06"},"enrollment":393,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Lymphoma"],"interventions":[{"type":"DRUG","name":"asparaginase","otherNames":["E.coli L-asparaginase","EC 3.5.2.2","colaspase","L-asnase","Elspar","Kidrolase","Crasnitin","Leunase","NSC#109229"]},{"type":"DRUG","name":"cyclophosphamide","otherNames":["Cytoxan","NSC #26271"]},{"type":"DRUG","name":"cytarabine","otherNames":["cytosine arabinoside","Ara-C","Cytosar","NSC #63878"]},{"type":"DRUG","name":"daunorubicin hydrochloride","otherNames":["daunomycin","rubidomycin","Cerubidine","NSC #82151"]},{"type":"DRUG","name":"dexamethasone","otherNames":["Decadron","Hexadrol","Dexone","Dexameth","NSC #34521"]},{"type":"DRUG","name":"doxorubicin hydrochloride","otherNames":["Adriamycin","NSC #123127"]},{"type":"DRUG","name":"leucovorin calcium","otherNames":["LCV","Wellcovorin","citrovorum factor","folinic acid","NSC #003590"]},{"type":"DRUG","name":"mercaptopurine","otherNames":["6-MP","Purinethol","6-mercaptopurine","NSC #000755"]},{"type":"DRUG","name":"methotrexate","otherNames":["MTX","amethopterin","Trexall","NSC #000740"]},{"type":"DRUG","name":"prednisone","otherNames":["Deltasone","Meticorten","Orasone","Liquid Pred","Pediapred","Sterapred","NSC #010023"]},{"type":"DRUG","name":"thioguanine","otherNames":["6-thioguanine","2-amino-1,7-dihydro-6H-purine-6-thione","WR-1141","Tabloid","Lanvis","NSC # 751"]},{"type":"DRUG","name":"vincristine sulfate","otherNames":["Oncovin","VCR","LCR","NSC #67574"]},{"type":"RADIATION","name":"radiation therapy","otherNames":[]}],"arms":[{"label":"A0 (localized disease Stg I/II) Modified CCG BFM","type":"EXPERIMENTAL"},{"label":"A1 (Disseminated, No CNS - CCG mod BFM w/out intens","type":"EXPERIMENTAL"},{"label":"A2 (Disseminated, No CNS - CCG mod BFM w/ intens","type":"EXPERIMENTAL"},{"label":"B2 (CNS+) NHL/BFM-95 w/intens delayed radiation therapy","type":"EXPERIMENTAL"},{"label":"B1 (Disseminated CNS- <Amend 7B) NHL/BFM-95 w/out intens","type":"EXPERIMENTAL"},{"label":"B2 (Disseminated,CNS- (< Amend 7B)) NHL/BFM-95 w/intens","type":"EXPERIMENTAL"},{"label":"B1 (Disseminated CNS-) NHL/BFM-95 w/out intens","type":"EXPERIMENTAL"}],"summary":"RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. It is not yet known which regimen of combination chemotherapy is most effective for lymphoblastic lymphoma.\n\nPURPOSE: This randomized phase III trial is studying different regimens of combination chemotherapy to compare how well they work in treating children or adolescents with newly diagnosed stage III or stage IV lymphoblastic lymphoma.","primaryOutcome":{"measure":"Event-free Survival","timeFrame":"5 years","effectByArm":[{"arm":"A0 (Localized Disease Stg I/II) Modified CCG BFM","deltaMin":88,"sd":null},{"arm":"A1 (Disseminated, No CNS - CCG Mod BFM w/Out Intens","deltaMin":82,"sd":null},{"arm":"A2 (Disseminated, No CNS - CCG Mod BFM w/ Intens","deltaMin":80,"sd":null},{"arm":"B2 (CNS+) NHL/BFM-95 w/Intens Delayed Radiation Therapy","deltaMin":63,"sd":null},{"arm":"B2 (Disseminated,CNS- (< Amend 7B)) NHL/BFM-95 w/Intens","deltaMin":82,"sd":null},{"arm":"B1 (Disseminated CNS-) NHL/BFM-95 w/Out Intens","deltaMin":84,"sd":null},{"arm":"B1 (NHL/BFM-95 w/Out Intens) Additional Enrollment","deltaMin":90,"sd":null}],"pValues":[{"comp":"OG001 vs OG002 vs OG003 vs OG005 vs OG006","p":".97"},{"comp":"OG001 vs OG002 vs OG003 vs OG005","p":".63"}]},"eligibility":{"minAge":"1 Year","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":176,"countries":["United States","Australia","Canada","Puerto Rico","Switzerland"]},"refs":{"pmids":["22994934","22488718","19546402","18618503"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":56},"commonTop":["Hemoglobin (Hgb)","Leukocytes (total WBC)","Platelets","SGPT (ALT)","Febrile neutropenia"]}}